A study identified a link between sex hormones and renal cell carcinoma, suggesting potential new treatment strategies.

A longstanding scientific belief about a link between cancer prevalence and animal body size has tested for the first time in ...

Peto’s paradox is that bigger, longer-lived species should have higher cancer prevalence, yet they don’t seem to. Back in ...

Renal cell carcinoma highlights from ASCO GU 2025 include follow-up data from the CheckMate 9ER study, updated COSMIC-313 results, and promising early data on casdatifan, a new HIF-2 alpha inhibitor.

A month has gone by since the last earnings report for Merck (MRK). Shares have added about 3.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...

A clinical trial demonstrates that personalised cancer vaccines effectively target mutations in high-risk kidney cancer, ...

OCONOMOWOC, Wis. - A fundraiser to support a Waukesha County deputy as he battles cancer raised nearly $25,000 at the end of ...

We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...

Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

The following is a summary of “Metabolic syndrome and increased susceptibility to renal cell carcinoma – a meta-analysis,” ...

Through this study, we aim to offer a new, innovative treatment to patients,” medical oncologist Dr. John Lenehan said.